Literature DB >> 9166872

A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction. Is it really a distinct disease?

H Mittre, P Leymarie, M Macro, M Leporrier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166872

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  Targeted therapy of chronic myeloid leukemia.

Authors:  Con Sullivan; Cong Peng; Yaoyu Chen; Dongguang Li; Shaoguang Li
Journal:  Biochem Pharmacol       Date:  2010-05-12       Impact factor: 5.858

2.  e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases.

Authors:  B C Mondal; S Majumdar; U B Dasgupta; U Chaudhuri; P Chakrabarti; S Bhattacharyya
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

3.  Exon-skipping in BCR/ABL is induced by ABL exon 2.

Authors:  B D Lichty; S Kamel-Reid
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

4.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.